Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption

Clinical Lung Cancer

Volumn 13, Issue 6, 2012, Pages 470-474

  Hollevoet, Kevin ^a   Speeckaert, Marijn M ^a   Decavele, An Sofie ^a   Vanholder, Raymond ^a   Van Meerbeeck, Jan P ^a   Delanghe, Joris R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Albumin; Alpha 1 microglobulin; Biomarker; Mesothelioma; Renal handling; Urine

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BIOLOGICAL MARKER; CREATININE; MESOTHELIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; GLOMERULAR LEAKAGE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TUBULE ABSORPTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MEASUREMENT; PROSPECTIVE STUDY; URINE LEVEL; VALIDATION PROCESS;

ADULT; AGED; ALBUMINURIA; ALPHA-GLOBULINS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; GLOMERULAR FILTRATION RATE; GPI-LINKED PROTEINS; HUMANS; KIDNEY DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84867529334     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.12.004     Document Type: Article

References (31)

1. B.W. Robinson, A.W. Musk, R.A. Lake Malignant mesothelioma Lancet 366 2005 397 408
2. B.W. Robinson, J. Creaney, R. Lake Mesothelin-family proteins and diagnosis of mesothelioma Lancet 362 2003 1612 1616
3. K. Hollevoet, K. Nackaerts, J. Thimpont Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma Am J Respir Crit Care Med 181 2010 620 625
4. J. Creaney, R.J. Francis, I.M. Dick Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden Clin Cancer Res 17 2011 1181 1189
5. P. Wheatley-Price, B. Yang, D. Patsios Soluble mesothelin-related peptide and osteopontin as markers of response in malignant mesothelioma J Clin Oncol 28 2010 3316 3322
6. K. Hollevoet, K. Nackaerts, R. Gosselin Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma J Thorac Oncol 6 2011 1930 1937
7. R. Hassan, M. Ho Mesothelin targeted cancer immunotherapy Eur J Cancer 44 2008 46 53
8. K. Chang, I. Pastan Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers Proc Natl Acad Sci U S A 93 1996 136 140
9. R. Hassan, Z.G. Laszik, M. Lerner Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis Am J Clin Pathol 124 2005 838 845
10. N. Scholler, N. Fu, Y. Yang Soluble member(s) of the mesothelin/ megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma Proc Natl Acad Sci U S A 96 1999 11531 11536
11. I. Hellstrom, J. Raycraft, S. Kanan Mesothelin variant 1 is released from tumor cells as a diagnostic marker Cancer Epidemiol Biomarkers Prev 15 2006 1014 1020
12. Z. Li, T. Verch, J.W. Allard MESOMARK® in vitro diagnostic test for mesothelioma Expert Opin Med Diagn 1 2007 137 142
13. R. Hassan, A.T. Remaley, M.L. Sampson Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer Clin Cancer Res 12 2006 447 453
14. K. Hollevoet, K. Nackaerts, O. Thas The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor Chest 141 2012 477 484
15. K. Hollevoet, D. Bernard, F. De Geeter Glomerular filtration rate is a confounder for determination of soluble mesothelin in serum Clin Chem 55 2009 1431 1433
16. E.K. Park, P.S. Thomas, J. Creaney Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population Clin Chem Lab Med 48 2010 869 874
17. D.G. Weber, G. Johnen, D. Taeger Assessment of confounding factors affecting the tumor markers SMRP, CA125, and CYFRA21-1 in serum Biomark Insights 5 2010 1 8
18. N. Boudville, R. Paul, B.W. Robinson Mesothelin and kidney function: analysis of relationship and implications for mesothelioma screening Lung Cancer 73 2011 320 324
19. D. Badgwell, Z. Lu, L. Cole Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment Gynecol Oncol 106 2007 490 497
20. J. Creaney, A.W. Musk, B.W. Robinson Sensitivity of urinary mesothelin in patients with malignant mesothelioma J Thorac Oncol 5 2010 1461 1466
21. J.R. Delanghe How to establish glomerular filtration rate in children Scand J Clin Lab Invest Suppl 241 2008 46 51
22. P.A. Peterson, P.E. Evrin, I. Berggard Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein J Clin Invest 48 1969 1189 1198
23. J. Penders, J.R. Delanghe Alpha 1-microglobulin: clinical laboratory aspects and application Clin Chim Acta 346 2004 107 118
24. L.M. Russo, R.M. Sandoval, S.B. Campos Impaired tubular uptake explains albuminuria in early diabetic nephropathy J Am Soc Nephrol 20 2009 489 494
25. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 607
26. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
27. P.J. Verroust, H. Birn, R. Nielsen The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology Kidney Int 62 2002 745 756
28. R.J. Baines, N.J. Brunskill Tubular toxicity of proteinuria Nat Rev Nephrol 7 2011 177 180
29. M.M. Speeckaert, R. Speeckaert, L. Van De Voorde Immunochemically unreactive albumin in urine: fiction or reality? Crit Rev Clin Lab Sci 48 2011 87 96
30. V. Launay-Vacher, J.B. Rey, C. Isnard-Bagnis Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care Cancer Chemother Pharmacol 61 2008 903 909
31. K. Hollevoet, J. Van Cleemput, J. Thimpont Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study J Thorac Oncol 6 2011 889 895